Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

NARecruitingINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Polycystic Ovarian Syndrome (PCOS)

Interventions

DRUG

Aromatase inhibitor Letrozole

2.5 mg tab twice daily from the 3rd day of the cycle for 5 days

Trial Locations (1)

RECRUITING

Kasr Alainy medical school, Cairo

All Listed Sponsors

lead

Cairo University

OTHER